Cost-benefit analysis of ivermectin, permethrin and benzyl benzoate in the management of infantile and childhood scabies.

Authors

M.L. Elgart

Document Type

Journal Article

Publication Date

2003

Journal

Expert Opinion on Pharmacotherapy

Volume

4

Issue

9

Inclusive Pages

1521-1524

Keywords

Dermatology

This document is currently not available here.

Share

COinS